Patents by Inventor Fred Van Aart

Fred Van Aart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7536226
    Abstract: An electro-nerve stimulation apparatus includes a pulse generator, a first electrically conductive, insulated lead wire, a second electrically conductive, insulated lead wire, an electrically conductive transcutaneous electrode and an electrically conductive percutaneous needle electrode. Connected to one end of the first and second lead wires is a connector for electrically coupling with the pulse generator. The transcutaneous electrode is operably connected to the other end of the first lead wire. An electrically conductive adaptor is secured to the other end of the second lead wire for electrically coupling to the terminal end of the percutaneous needle electrode. The lead wire set includes a single-use mechanism adapted to effectively discourage reuse of the electrodes. In use, the transcutaneous electrode is adhered to the patient's skin distal from the desired internal stimulation site. The percutaneous needle electrode is inserted through the skin in proximity to the desired internal stimulation site.
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: May 19, 2009
    Assignee: Uroplasty, Inc.
    Inventors: Jeffrey M. Williams, Fred Van Aart, Hans Van Den Biggelaar, Petronella Maria Coleta van Laanen, legal representative, Plet Van Helvoirt
  • Publication number: 20050171576
    Abstract: An electro-nerve stimulation apparatus includes a pulse generator, a first electrically conductive, insulated lead wire, a second electrically conductive, insulated lead wire, an electrically conductive transcutaneous electrode and an electrically conductive percutaneous needle electrode. Connected to one end of the first and second lead wires is a connector for electrically coupling with the pulse generator. The transcutaneous electrode is operably connected to the other end of the first lead wire. An electrically conductive adaptor is secured to the other end of the second lead wire for electrically coupling to the terminal end of the percutaneous needle electrode. The lead wire set includes a single-use mechanism adapted to effectively discourage reuse of the electrodes. In use, the transcutaneous electrode is adhered to the patient's skin distal from the desired internal stimulation site. The percutaneous needle electrode is inserted through the skin in proximity to the desired internal stimulation site.
    Type: Application
    Filed: October 18, 2002
    Publication date: August 4, 2005
    Applicant: Cystomedix, Inc
    Inventors: Jeffrey Williams, Fred Van Aart, Hans Van Den Biggelaar, Piet Van Helvoirt, Petronella van Laanen